← All trials
NCT04879888
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2016
- Primary completion
- Dec 30, 2016
- Completion date
- Jul 30, 2017
- First posted
- May 10, 2021
- Last posted
- May 10, 2021
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Universidad Nacional de ColombiaLead sponsor
- Universidad Nacional de ColombiaReponsible party - principal investigator
- Fundación Salud de los AndesCollaborator
- Fundacion Investigacion y DesarrolloCollaborator
- Subred Integrada de Servicios de Salud Sur ESE - ColombiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.